Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2019-10-03 Capital/Financing Update
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Non-Renounceable Rights Issue 3 pages 181.8KB
Capital/Financing Update Classification · 100% confidence The document is an ASX Market Announcement detailing a Non-Renounceable Rights Issue by Genetic Technologies Limited. It includes specifics about the rights offer, share issuance, pricing, record date, timetable, and use of proceeds. The content focuses on fundraising and capital structure changes through issuing new shares to existing shareholders. There are no financial statements or detailed financial performance data, so it is not an Annual Report or Interim Report. It is not a report publication announcement since it contains substantive information about the capital raising event itself. The document fits the definition of a Capital/Financing Update (CAP) as it provides an update on the company's fundraising activity and capital structure changes.
2019-10-03 English
Appendix 3B - Rights Issue 13 pages 243.1KB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form, which is a standard Australian Securities Exchange (ASX) form used for announcements related to new issues of securities, applications for quotation of additional securities, and agreements related to these securities. The text includes detailed information about the class of securities issued, number of securities, issue price, purpose of the issue, security holder approvals, and quotation agreements. It is not a financial report, earnings release, or management discussion, but rather a formal announcement of a capital raising event and related securities issuance. This fits the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising, financing activities, or capital structure changes.
2019-10-03 English
Cleansing Notice under Section 708AA of the Corporations Act 3 pages 149.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX Market Announcement titled 'Cleansing Notice under Section 708AA of the Corporations Act 2001 (Cth)' dated 4 October 2019. It announces a non-renounceable rights issue to eligible shareholders, detailing the terms of the rights issue, the number of shares to be issued, and the potential effect on control of the company. The document does not contain financial statements or detailed financial analysis but is an announcement related to a capital raising event. It is not a full financial report, earnings release, or management discussion. The content fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes. The document length is 4538 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the appropriate classification is CAP with high confidence.
2019-10-03 English
Letters to Optionholders - Rights Issue 3 pages 143.7KB
Capital/Financing Update Classification · 95% confidence The document is a letter dated 4 October 2019 from Genetic Technologies Limited to optionholders regarding a non-renounceable pro-rata rights issue offer. It explains the terms of the rights issue, eligibility criteria, the timetable for the offer, and instructions for optionholders on exercising options to participate. The content focuses on informing shareholders about a capital raising event and the rights issue process. There are no financial statements or detailed financial analysis included, only an announcement and explanation of the rights issue offer. This fits the category of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes.
2019-10-03 English
Annual Report to shareholders 77 pages 8.1MB
Regulatory Filings
2019-09-30 English
Appendix 4G and Corporate Governance Statement 28 pages 304.6KB
Governance Information Classification · 70% confidence The document text is heavily corrupted or contains unreadable characters, making it impossible to extract meaningful content or keywords. However, the visible text includes the phrase 'Appendix 4G' and references to 'Corporate Governance Council Principles and Recommendations.' Appendix 4G is commonly associated with corporate governance disclosures, which align with governance reporting. There is no indication of financial data, earnings, management changes, or other report types. Given the focus on governance principles and recommendations, the document most likely pertains to Governance Information (CGR). The document length is substantial (15,000 characters), indicating it is a full report rather than a brief announcement. Therefore, the best classification is Governance Information (CGR) with moderate confidence due to the corrupted text limiting certainty.
2019-09-30 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.